
1. antimicrob agents chemother. 2019 may 24;63(6). pii: e00342-19. doi:
10.1128/aac.00342-19. print 2019 jun.

lysocins: bioengineered antimicrobials deliver lysins across outer
membrane gram-negative bacteria.

heselpoth rd(1), euler cw(2)(3)(4), schuch r(5), fischetti va(2).

author information: 
(1)laboratory bacterial pathogenesis immunology, rockefeller
university, new york, new york, usa rheselpoth@rockefeller.edu.
(2)laboratory bacterial pathogenesis immunology, rockefeller
university, new york, new york, usa.
(3)department medical laboratory sciences, hunter college, cuny, new york, new
york, usa.
(4)department microbiology immunology, weill cornell medical college, new 
york, new york, usa.
(5)contrafect corporation, yonkers, new york, usa.

the prevalence multidrug-resistant pseudomonas aeruginosa stimulated
development alternative therapeutics. bacteriophage peptidoglycan hydrolases, 
termed lysins, represent emerging antimicrobial option targeting
gram-positive bacteria. however, lysins gram-negatives generally
deterred outer membrane inability work serum. one solution
involves exploiting evolved delivery systems used colicin-like bacteriocins
(e.g., s-type pyocins p. aeruginosa) translocate outer
membrane. following surface receptor binding, colicin-like bacteriocins form tol-
or tonb-dependent translocons actively import bactericidal domains through
outer membrane protein channels. understanding, developed lysocins, 
which bioengineered lysin-bacteriocin fusion molecules capable periplasmic
import. proof-of-concept studies, components p. aeruginosa
bacteriocin pyocin s2 (pys2) responsible surface receptor binding outer
membrane translocation fused gn4 lysin generate pys2-gn4
lysocin. pys2-gn4 delivered gn4 lysin periplasm induce
peptidoglycan cleavage log-fold killing p. aeruginosa minimal
endotoxin release. displaying narrow-spectrum antipseudomonal activity in
human serum, pys2-gn4 also efficiently disrupted biofilms, outperformed
standard-of-care antibiotics, exhibited cytotoxicity toward eukaryotic cells, 
and protected mice p. aeruginosa challenge bacteremia model. in
addition targeting p. aeruginosa, lysocins constructed target 
prominent gram-negative bacterial pathogens.

copyright Â© 2019 american society microbiology.

doi: 10.1128/aac.00342-19 
pmcid: pmc6535517
pmid: 30962344  [indexed medline]

